MYRIAD GENETICS, INC. Executive Retention AgreementRetention Agreement • February 6th, 2007 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
Contract Type FiledFebruary 6th, 2007 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Mark C. Capone (the “Executive”), is made as of November 17, 2006 (the “Effective Date”).